Paper39109552
How Does the Powder Mixture of Ibuprofen and Caffeine Attenuate the Solubility of Ibuprofen? Comparative Study for the Xanthine Derivatives to Recognize Their Intermolecular Interactions Using Fourier-Transform Infrared (FTIR) Spectra, Differential Scanning Calorimetry (DSC), and X-ray Powder Diffractometry (XRPD).
Suenaga S and 7 others. Mol Pharm, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. How Does the Powder Mixture of Ibuprofen and Caffeine Attenuate the Solubility of Ibuprofen? Comparative Study for the Xanthine Derivatives to Recognize Their Intermolecular Interactions Using Fourier-Transform Infrared (FTIR) Spectra, Differential Scanning Calorimetry (DSC), and X-ray Powder Diffractometry (XRPD). Papers, record 39109552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39109552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
How Does the Powder Mixture of Ibuprofen and Caffeine Attenuate the Solubility of Ibuprofen? Comparative Study for the Xanthine Derivatives to Recognize Their Intermolecular Interactions Using Fourier-Transform Infrared (FTIR) Spectra, Differential Scanning Calorimetry (DSC), and X-ray Powder Diffractometry (XRPD).
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Caffeine | Major topic |
| Ibuprofen | Major topic |
| Solubility | Major topic |
| Calorimetry, Differential Scanning | Major topic |
| Powders | Major topic |
| X-Ray Diffraction | Major topic |
| Spectroscopy, Fourier Transform Infrared | |
| Theophylline | |
| Chromatography, High Pressure Liquid | |
| Theobromine | |
| Diclofenac | |
| Xanthine |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16853045 | Plastic and glassy crystal states of caffeine. | J Phys Chem B | 2005 | https://conductscience.org/library/papers/16853045 | PubMed |
| 2 | 34712848 | Singular value decomposition analysis of the secondary structure features contributing to the circular dichroism spectra of model proteins. | Biochem Biophys Rep | 2021 | https://conductscience.org/library/papers/34712848 | PubMed |
| 3 | 35110432 | Enthalpy-Entropy Compensation in the Structure-Dependent Effect of Nonsteroidal Anti-inflammatory Drugs on the Aqueous Solubility of Diltiazem. | Chem Pharm Bull (Tokyo) | 2022 | https://conductscience.org/library/papers/35110432 | PubMed |
| 4 | 20182037 | Caffeine and coffee as therapeutics against Alzheimer's disease. | J Alzheimers Dis | 2010 | https://conductscience.org/library/papers/20182037 | PubMed |
| 5 | 20859799 | Methylxanthines, seizures, and excitotoxicity. | Handb Exp Pharmacol | 2011 | https://conductscience.org/library/papers/20859799 | PubMed |
| 6 | 2184730 | Clinical pharmacology of caffeine. | Annu Rev Med | 1990 | https://conductscience.org/library/papers/2184730 | PubMed |
| 7 | 35101827 | Increased selectivity of sodium deoxycholate to around Tryptophan213 in bovine serum albumin upon micellization as revealed by singular value decomposition for excitation emission matrix. | Colloids Surf B Biointerfaces | 2022 | https://conductscience.org/library/papers/35101827 | PubMed |
| 8 | 20492310 | Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. | J Food Sci | 2010 | https://conductscience.org/library/papers/20492310 | PubMed |
| 9 | 836503 | Substituent constants for correlation analysis. | J Med Chem | 1977 | https://conductscience.org/library/papers/836503 | PubMed |
| 10 | 19429297 | Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. | Int J Pharm | 2009 | https://conductscience.org/library/papers/19429297 | PubMed |
| 11 | 30762305 | Physiologically-Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam. | CPT Pharmacometrics Syst Pharmacol | 2019 | https://conductscience.org/library/papers/30762305 | PubMed |
| 12 | 37024067 | Optimization of the stability constants of the ternary system of diclofenac/famotidine/β-cyclodextrin by nonlinear least-squares method using theoretical equations. | Int J Pharm | 2023 | https://conductscience.org/library/papers/37024067 | PubMed |
| 13 | 29121285 | Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature. | Br J Anaesth | 2017 | https://conductscience.org/library/papers/29121285 | PubMed |
| 14 | 12519715 | Effects of caffeine on human health. | Food Addit Contam | 2003 | https://conductscience.org/library/papers/12519715 | PubMed |
| 15 | 37688787 | Effect of Cyclodextrin Complex Formation on Solubility Changes of Each Drug Due to Intermolecular Interactions between Acidic NSAIDs and Basic H2 Blockers. | Mol Pharm | 2023 | https://conductscience.org/library/papers/37688787 | PubMed |
| 16 | 36127354 | The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19. | NPJ Prim Care Respir Med | 2022 | https://conductscience.org/library/papers/36127354 | PubMed |
| 17 | 37242514 | Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242514 | PubMed |
| 18 | 17676317 | The caffeine contents of dietary supplements commonly purchased in the US: analysis of 53 products with caffeine-containing ingredients. | Anal Bioanal Chem | 2007 | https://conductscience.org/library/papers/17676317 | PubMed |
| 19 | 37104048 | Effects of Local Anesthetics on Liposomal Membranes Determined by Their Inhibitory Activity of Lipid Peroxidation. | Mol Pharm | 2023 | https://conductscience.org/library/papers/37104048 | PubMed |
| 20 | 38292264 | Quantification of crystallinity during indomethacin crystalline transformation from α- to γ-polymorphic forms and of the thermodynamic contribution to dissolution in aqueous buffer and solutions of solubilizer. | RSC Adv | 2024 | https://conductscience.org/library/papers/38292264 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42796476 | A Comprehensive Study of a New Norfloxacin-Niflumate Hydrate: Structural and Physicochemical Properties, Antibiotic Potency, Anti-Inflammatory Effect, and Drug Safety. | Molecules | 2026 | https://conductscience.org/library/papers/42796476 | PubMed |
| 40594879 | Study of caspase-6 activity in aggressive HCT116 cells using methotrexate-encapsulated lactoferrin-conjugated solid lipid nanoparticles via in silico and in vitro approaches. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594879 | PubMed |
| 39772649 | Stability and Properties of Ultraviolet Filter Avobenzone under Its Diketo/Enol Tautomerization Induced by Molecular Encapsulation with β-Cyclodextrin. | Langmuir | 2025 | https://conductscience.org/library/papers/39772649 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39109552
GET https://conductscience.org/api/papers/v1/39109552/references?page=2